Merck Company Stock Analysis

MRK Stock  USD 129.49  1.60  1.22%   
Merck Company is overvalued with Real Value of 122.53 and Target Price of 117.2. The main objective of Merck stock analysis is to determine its intrinsic value, which is an estimate of what Merck Company is worth, separate from its market price. There are two main types of Merck's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Merck's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Merck's stock to identify patterns and trends that may indicate its future price movements.
The Merck stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Merck is usually not traded on Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Merck Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Merck's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Merck Stock Analysis Notes

About 79.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.1. Merck Company last dividend was issued on the 14th of March 2024. The entity had 1048:1000 split on the 3rd of June 2021. Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 67000 people. To find out more about Merck Company contact Kenneth Frazier at 908 740 4000 or learn more at https://www.merck.com.

Merck Quarterly Total Revenue

14.63 Billion

Merck Company Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Merck's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Merck Company or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Merck Company has a strong financial position based on the latest SEC filings
Over 79.0% of the company shares are owned by institutional investors
On 5th of April 2024 Merck paid $ 0.77 per share dividend to its current shareholders
Latest headline from seekingalpha.com: Merck, Kelun buoyed by phase 3 results for breast cancer antibody drug conjugate

Merck Company Upcoming and Recent Events

Earnings reports are used by Merck to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Merck previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
25th of April 2024
Upcoming Quarterly Report
View
6th of August 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
6th of February 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

Merck Largest EPS Surprises

Earnings surprises can significantly impact Merck's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2010-05-04
2010-03-310.750.830.0810 
2006-07-24
2006-06-300.650.730.0812 
2014-04-29
2014-03-310.790.880.0911 
View All Earnings Estimates

Merck Environmental, Social, and Governance (ESG) Scores

Merck's ESG score is a quantitative measure that evaluates Merck's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Merck's operations that may have significant financial implications and affect Merck's stock price as well as guide investors towards more socially responsible investments.

Merck Thematic Classifications

In addition to having Merck stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Giant Impact Idea
Giant Impact
Public companies with mega capitalization
Robots And Drones Idea
Robots And Drones
Cross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions
Compulsion Idea
Compulsion
Addiction driven consumer products and services

Merck Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Merck is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Merck Company backward and forwards among themselves. Merck's institutional investor refers to the entity that pools money to purchase Merck's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Jpmorgan Chase & Co2023-12-31
25.4 M
Goldman Sachs Group Inc2023-12-31
24.2 M
Legal & General Group Plc2023-12-31
23.5 M
Deutsche Bank Ag2023-12-31
21.6 M
Bank Of New York Mellon Corp2023-12-31
20.8 M
Charles Schwab Investment Management Inc2024-03-31
17.7 M
Amvescap Plc.2023-12-31
16.8 M
Nuveen Asset Management, Llc2023-12-31
16.7 M
Ameriprise Financial Inc2023-12-31
16.4 M
Vanguard Group Inc2024-03-31
243.3 M
Blackrock Inc2023-12-31
201.8 M
Note, although Merck's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Merck Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 327.97 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck's market, we take the total number of its shares issued and multiply it by Merck's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Merck Profitablity

Merck's profitability indicators refer to fundamental financial ratios that showcase Merck's ability to generate income relative to its revenue or operating costs. If, let's say, Merck is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Merck's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Merck's profitability requires more research than a typical breakdown of Merck's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.04 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.42 %, which entails that for every 100 dollars of revenue, it generated $0.42 of operating income.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.01  0.01 
Return On Capital Employed 0.04  0.04 
Return On Assets 0  0 
Return On Equity 0.01  0.01 

Management Efficiency

Merck Company has Return on Asset of 0.1026 % which means that on every $100 spent on assets, it made $0.1026 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0531 %, implying that it generated $0.0531 on every 100 dollars invested. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to 0.01. The value of Return On Capital Employed is expected to slide to 0.04. At this time, Merck's Non Current Liabilities Total is quite stable compared to the past year. Non Current Liabilities Other is expected to rise to about 10.8 B this year, although the value of Total Current Liabilities will most likely fall to about 13.3 B.
Last ReportedProjected for Next Year
Book Value Per Share 14.81  15.55 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share(0.62)(0.59)
Enterprise Value Over EBITDA 44.64  46.87 
Price Book Value Ratio 7.36  6.91 
Enterprise Value Multiple 44.64  46.87 
Price Fair Value 7.36  6.91 
Enterprise Value185.4 B194.7 B
The analysis of Merck's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Merck's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Merck Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield
0.0238
Forward Dividend Yield
0.0238
Forward Dividend Rate
3.08
Beta
0.402

Technical Drivers

As of the 26th of May, Merck secures the Risk Adjusted Performance of 0.0142, downside deviation of 0.7413, and Mean Deviation of 0.6553. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Merck Company, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Merck, which can be compared to its peers in the industry. Please verify Merck Company variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Merck Company is priced some-what accurately, providing market reflects its recent price of 129.49 per share. Given that Merck Company has jensen alpha of (0.02), we recommend you to check Merck's last-minute market performance to make sure the company can sustain itself at a future point.

Merck Company Price Movement Analysis

Execute Study
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Merck middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Merck Company. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Merck Company Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Merck insiders, such as employees or executives, is commonly permitted as long as it does not rely on Merck's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Merck insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Merck Outstanding Bonds

Merck issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Merck Company uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Merck bonds can be classified according to their maturity, which is the date when Merck Company has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Merck Predictive Daily Indicators

Merck intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Merck stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Merck Corporate Filings

20th of May 2024
Other Reports
ViewVerify
FWP
16th of May 2024
A written communication used by offering participants to offer securities to the public or to solicit securities transactions.
ViewVerify
15th of May 2024
Other Reports
ViewVerify
F4
6th of May 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10Q
3rd of May 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
F4
2nd of May 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
25th of April 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
10K
11th of April 2024
An amendment to a previously filed Form 10-K
ViewVerify

Merck Forecast Models

Merck's time-series forecasting models are one of many Merck's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Merck's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Merck Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Merck prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Merck shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Merck. By using and applying Merck Stock analysis, traders can create a robust methodology for identifying Merck entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.03  0.03 
Operating Profit Margin 0.05  0.05 
Net Profit Margin 0.01  0.01 
Gross Profit Margin 0.73  0.74 

Current Merck Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Merck analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Merck analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
117.2Strong Buy28Odds
Merck Company current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Merck analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Merck stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Merck Company, talking to its executives and customers, or listening to Merck conference calls.
Merck Analyst Advice Details

Merck Stock Analysis Indicators

Merck Company stock analysis indicators help investors evaluate how Merck stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Merck shares will generate the highest return on investment. By understating and applying Merck stock analysis, traders can identify Merck position entry and exit signals to maximize returns.
Begin Period Cash Flow12.8 B
Long Term Debt33.7 B
Common Stock Shares Outstanding2.5 B
Total Stockholder Equity37.6 B
Total Cashflows From Investing Activities-14.1 B
Tax Provision2.8 B
Quarterly Earnings Growth Y O Y0.685
Property Plant And Equipment Net24.5 B
Cash And Short Term Investments7.2 B
Cash6.9 B
Accounts Payable3.9 B
Net Debt29.4 B
50 Day M A127.9412
Total Current Liabilities25.7 B
Other Operating Expenses56.9 B
Non Current Assets Total74.5 B
Forward Price Earnings14.6843
Non Currrent Assets Other9.2 B
Stock Based Compensation645 M
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.685
Dividend Share
2.96
Earnings Share
0.91
Revenue Per Share
24.215
Quarterly Revenue Growth
0.089
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.